Reading Time: 2 minutesOn Friday 5 May in America, the FDA, the organisation that approves drugs, announced that they’d granted a licence for the drug known as a
Category: Clinical Trials
27th Symposium: Dublin 2016 Causes and disease mechanisms Clinical Trials MND Research News Symposium
Prize winning posters in Dublin
Reading Time: 4 minutesAs well as all the networking, debate and new information being shared, the International Symposium on ALS/MND is also a time to celebrate achievements by
Reading Time: 2 minutesA few months ago we wrote an article about the ALS Clinical Trials Workshop which took place in Virginia, USA. Since then the Guidelines Working
Reading Time: 3 minutesTo mark International Clinical Trials Day (20 May) we reflect on the ALS Clinical Trials Guidelines workshop that took place in March. The MND Association
Reading Time: 4 minutesThe recent announcement about the use of stem cells to treat a form of multiple sclerosis (MS), together with early results from the BrainStorm stem
Reading Time: 5 minutesClinical trials determine if potential treatments are safe and aim to prove beyond reasonable doubt whether a drug is beneficial. They are therefore the gold
Reading Time: 3 minutesBar a few bacteria usually found hitching a ride on our dental plaque and digestive system, every living cell in the human body needs oxygen.
Reading Time: 5 minutesA clinical trial of Jedi proportions… The MND Association is backing a new clinical trial in MND, known as MIROCALS. This will be a joint
Reading Time: 3 minutesThe MND Association’s Director of Research, Brian Dickie explains more about ‘GM6’, also known as ‘GM604’, a drug in development by an American pharmaceutical company
Reading Time: 4 minutesThe 25th International Symposium on ALS/MND began today in Brussels, Belgium. More than 900 delegates joined the opening session to hear Dr Alfred Sandrock from